中科曙光 reported revenue of ¥7.47B for the period ended 2026-06-30, +27.6% year on year. Net income was ¥0.93B, a 12.4% net margin on a 27.2% gross margin. The largest revenue line is IT设备 at 89% of the total. Free cash flow for the period was ¥0.91B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥7.47B | +27.6% |
| Gross profit | ¥2.03B | — |
| Operating income | ¥1.12B | — |
| Net income | ¥0.93B | +32.4% |
| Gross margin | 27.2% | Net margin 12.4% |
| Revenue Q/Q | +33.3% | — |
| Segment | Revenue | Share |
|---|---|---|
| IT设备 | ¥6.67B | 89.3% |
| 软件开发、系统集成及技术服务 | ¥0.79B | 10.6% |
| 其他(补充) | ¥0.01B | 0.1% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥5.43B | 72.8% |
| R&D | ¥0.99B | 13.2% |
| SG&A | ¥0.51B | 6.8% |
| Tax & other | ¥0.19B | 2.6% |
| Item | Amount |
|---|---|
| Total assets | ¥43.22B |
| Total liabilities | ¥19.60B |
| Shareholders' equity | ¥23.61B |
| Equity / assets | 54.6% |
| Operating cash flow | ¥1.20B |
| Capital expenditure | ¥0.29B |
| Free cash flow | ¥0.91B |
| Cash conversion (OCF / net income) | -20% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
药明康德 ・ 合盛硅业 ・ 海天味业 ・ 华勤技术 ・ 今世缘 ・ 万泰生物 ・ 豪威集团 ・ 华友钴业 ・ 瑞芯微 ・ 兆易创新 ・ 洛阳钼业 ・ 德业股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies